Search

Your search keyword '"Chang, G-C"' showing total 167 results
Start Over Author "Chang, G-C"
167 results on '"Chang, G-C"'

1. Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSA

Author

Felip, E., Cho, B.C., Gutiérrez, V., Alip, A., Besse, B., Lu, S., Spira, A.I., Girard, N., Califano, R., Gadgeel, S.M., Yang, J.C.-H., Yamamoto, S., Azuma, K., Kim, Y.J., Lee, K.-H., Danchaivijitr, P., Ferreira, C.G., Cheng, Y., Sendur, M.A.N., Chang, G.-C., Wang, C.-C., Prabhash, K., Shinno, Y., Stroyakovskiy, D., Paz-Ares, L., Rodriguez-Cid, J.R., Martin, C., Campelo, M.R.G., Hayashi, H., Nguyen, D., Tomasini, P., Gottfried, M., Dooms, C., Passaro, A., Schuler, M., Gelatti, A.C.Z., Owen, S., Perdrizet, K., Ou, S.-H.I., Curtin, J.C., Zhang, J., Gormley, M., Sun, T., Panchal, A., Ennis, M., Fennema, E., Daksh, M., Sethi, S., Bauml, J.M., and Lee, S.-H.

Published
2024
Full Text
View/download PDF

4. OA04.04 The Registry of Genetic Alterations of Taiwan NSCLC by Comprehensive Next-Generation Sequencing: A Real-World Cohort Study - TCOG T1521 Study

Author

Liao, B.-C., primary, Chiang, N.-J., additional, Chang, G.-C., additional, Su, W.-C., additional, Chong, I.-W., additional, Yang, T.-Y., additional, Luo, Y.-H., additional, Lai, C.-L., additional, Hsia, T.-C., additional, Ho, C.-L., additional, Lee, K.-Y., additional, Hsiao, C.-F., additional, and Yang, J.C.-H., additional

Published
2023
Full Text
View/download PDF

6. 148P AdvanTIG-105: Phase Ib dose-expansion study of ociperlimab (OCI) + tislelizumab (TIS) with chemotherapy in patients (pts) with extensive-stage small cell lung cancer (ES-SCLC)

Author

Zhang, J., primary, Hussein, M., additional, Kao, S.C-H., additional, Clay, T.D., additional, Singhal, N., additional, Kim, H.R., additional, Cho, E.K., additional, Shim, B., additional, Lee, Y., additional, Lee, G-W., additional, Zhao, J., additional, Yu, Y., additional, Sun, M., additional, Lin, C-B., additional, Yang, T-Y., additional, Chang, G-C., additional, Zheng, H., additional, Tan, W., additional, and Spigel, D.R., additional

Published
2022
Full Text
View/download PDF

9. EP08.01-073 AdvanTIG-105: Phase 1b Dose-Expansion Study of Ociperlimab plus Tislelizumab in Patients with Metastatic NSCLC

Author

Kumar, R., primary, Kim, S.H., additional, Zhong, D., additional, Lu, S., additional, Cheng, Y., additional, Chen, M., additional, Cho, E., additional, Clay, T., additional, Kang, J.-H., additional, Lee, G.-W., additional, Sun, M., additional, Shim, B.-Y., additional, Spigel, D.R., additional, Yang, T.-Y., additional, Wang, Q., additional, Chang, G.-C., additional, Yu, G., additional, Wang, R., additional, Luo, X., additional, Zheng, H., additional, Gao, R., additional, and Kim, H.R., additional

Published
2022
Full Text
View/download PDF

14. OA02.05 Lazertinib vs Osimertinib in 1L EGFR-Mutant Advanced NSCLC: A Randomized, Double-Blind, Exploratory Analysis from MARIPOSA

Author

Lee, S.-H., Cho, B.C., Hayashi, H., Felip, E., Spira, A.I., Girard, N., Kim, Y.J., Ostapenko, Y., Danchaivijitr, P., Liu, B., Alip, A., Korbenfeld, E., Mourão Dias, J., Lee, K.H., Xiong, H., How, S.H., Cheng, Y., Chang, G.-C., Yang, J.C.-H., Besse, B., Thomas, M., Curtin, J.C., Zhang, J., Xie, J., Sun, T., Martinez, M., Sethi, S., Knoblauch, R.E., Fennema, E., Daksh, M., Ennis, M., Bauml, J.M., and Lu, S.

Published
2024
Full Text
View/download PDF

16. 35P Real-world treatment outcomes of amivantamab in pre-approval access (PAA) participants with advanced non-small cell lung cancer (NSCLC) with EGFR exon 20 insertion mutations (ex20ins)

Author

Kim, T.M., primary, Lee, S-H., additional, Chang, G-C., additional, Shih, J-Y., additional, Hochmair, M.J., additional, Sabari, J.K., additional, Spira, A.I., additional, Schioppa, C.A., additional, Rose, J.B., additional, Chioda, M., additional, Panaccione, A., additional, Mahadevia, P., additional, and Cho, B.C., additional

Published
2022
Full Text
View/download PDF

17. 1197P First-line lorlatinib versus crizotinib in ALK-positive non-small cell lung cancer: Asian subgroup analysis of CROWN

Author

Zhou, Q., primary, Kim, H.R., additional, Soo, R., additional, Chang, G-C., additional, Chiu, C-H., additional, Hayashi, H., additional, Kim, S-W., additional, Teraoka, S., additional, Goto, Y., additional, Zhou, J., additional, Lee, V.H.F., additional, Han, B., additional, Ho, J.C.M., additional, Kim, D-W., additional, Lin, C-C., additional, Lu, S., additional, Polli, A., additional, Calella, A.M., additional, Mok, T.S.K., additional, and Wu, Y-L., additional

Published
2021
Full Text
View/download PDF

18. 1208P Final results of APOLLO study: Overall survival (OS) of aumolertinib in patients with pretreated EGFR T790M-positive locally advanced or metastatic non-small cell lung cancer (NSCLC)

Author

Lu, S., primary, Wang, Q., additional, Zhang, G., additional, Dong, X., additional, Yang, C-T., additional, Song, Y., additional, Chang, G-C., additional, Lu, Y., additional, Pan, H., additional, Chiu, C-H., additional, Wang, Z., additional, Feng, J., additional, Zhou, J., additional, Xu, X., additional, Guo, R., additional, Chen, J., additional, Yang, H., additional, Chen, Y., additional, Yu, Z., additional, and Shiah, H-S., additional

Published
2021
Full Text
View/download PDF

20. Tuberculosis infection and lung adenocarcinoma: Mendelian randomization and pathway analysis of genome-wide association study data from never-smoking Asian women

Author

Wong, J.Y.Y., Hsiung, C.A., Matsuo, K., Wong, M.P., Seow, W.J., Song, M., Chang, I.-S., Chatterjee, N., Hu, W., Wu, C., Mitsudomi, T., Zheng, W., Kim, J.H., Seow, A., Caporaso, N.E., Shin, M.-H., Chung, L.P., An, S.-J., Zheng, H., Yatabe, Y., Kim, Y.T., Cai, Q., Kim, Y.-C., Bassig, B.A., Ho, J.C.M., Ji, B.-T., Daigo, Y., Ito, H., Momozawa, Y., Ashikawa, K., Kamatani, Y., Honda, T., Hosgood, H.D., Sakamoto, H., Kunitoh, H., Tsuta, K., Watanabe, S.-I., Kubo, M., Miyagi, Y., Nakayama, H., Matsumoto, S., Tsuboi, M., Goto, K., Song, L., Hua, X., Takahashi, A., Goto, A., Minamiya, Y., Shimizu, K., Tanaka, K., Wei, F., Matsuda, F., Kim, Y.H., Oh, I.-J., Song, F., Su, W.-C., Chang, G.-C., Chen, K.-Y., Chien, L.-H., Xiang, Y.-B., Kweon, S.-S., Lee, K.-M., Blechter, B., Qian, B., Lu, D., Jeon, H.-S., Hsiao, C.-F., Sung, J.S., Tsai, Y.-H., Jung, Y.J., Chung, C.C., Burdett, L., Yeager, M., Hutchinson, A., Berndt, S.I., Pang, H., Choi, J.E., Park, K.H., Sung, S.W., Zhu, M., Guan, P., Tan, W., Hsin, M., Sit, K.-Y., Ho, J., Choi, Y.Y., Kim, J.S., Yoon, H.I., Park, I.K., Xu, P., He, Q., Perng, R.-P., Vermeulen, R., Lim, W.-Y., Chen, K.-C., Jin, L., Jiang, S.-S., Yamaji, T., Hicks, B., Wyatt, K., Dai, J., Jin, G., Song, B., Cheng, S., Cui, P., Iwasaki, M., Shimazu, T., Tsugane, S., Fei, K., Wu, G., Lin, H.-C., Fang, Y.-H., Tsai, F.-Y., Hsieh, W.-S., Yu, J., Stevens, V.L., Laird-Offringa, I.A., Marconett, C.N., Rieswijk, L., Chao, A., Shu, X.-O., Lin, D., Chen, K., Zhou, B., Kohno, T., Shen, H., Chanock, S.J., Rothman, N., Lan, Q., IRAS OH Epidemiology Chemical Agents, and dIRAS RA-2

Subjects
Lung adenocarcinoma, Pathway analysis, Mendelian randomization, Tuberculosis, Lung cancer
Abstract

We investigated whether genetic susceptibility to tuberculosis (TB) influences lung adenocarcinoma development among never-smokers using TB genome-wide association study (GWAS) results within the Female Lung Cancer Consortium in Asia. Pathway analysis with the adaptive rank truncated product method was used to assess the association between a TB-related gene-set and lung adenocarcinoma using GWAS data from 5512 lung adenocarcinoma cases and 6277 controls. The gene-set consisted of 31 genes containing known/suggestive associations with genetic variants from previous TB-GWAS. Subsequently, we followed-up with Mendelian Randomization to evaluate the association between TB and lung adenocarcinoma using three genome-wide significant variants from previous TB-GWAS in East Asians. The TB-related gene-set was associated with lung adenocarcinoma (p = 0.016). Additionally, the Mendelian Randomization showed an association between TB and lung adenocarcinoma (OR = 1.31, 95% CI: 1.03, 1.66, p = 0.027). Our findings support TB as a causal risk factor for lung cancer development among never-smoking Asian women.

Published
2020

21. Tuberculosis infection and lung adenocarcinoma: Mendelian randomization and pathway analysis of genome-wide association study data from never-smoking Asian women

Author

IRAS OH Epidemiology Chemical Agents, dIRAS RA-2, Wong, J.Y.Y., Hsiung, C.A., Matsuo, K., Wong, M.P., Seow, W.J., Song, M., Chang, I.-S., Chatterjee, N., Hu, W., Wu, C., Mitsudomi, T., Zheng, W., Kim, J.H., Seow, A., Caporaso, N.E., Shin, M.-H., Chung, L.P., An, S.-J., Zheng, H., Yatabe, Y., Kim, Y.T., Cai, Q., Kim, Y.-C., Bassig, B.A., Ho, J.C.M., Ji, B.-T., Daigo, Y., Ito, H., Momozawa, Y., Ashikawa, K., Kamatani, Y., Honda, T., Hosgood, H.D., Sakamoto, H., Kunitoh, H., Tsuta, K., Watanabe, S.-I., Kubo, M., Miyagi, Y., Nakayama, H., Matsumoto, S., Tsuboi, M., Goto, K., Song, L., Hua, X., Takahashi, A., Goto, A., Minamiya, Y., Shimizu, K., Tanaka, K., Wei, F., Matsuda, F., Kim, Y.H., Oh, I.-J., Song, F., Su, W.-C., Chang, G.-C., Chen, K.-Y., Chien, L.-H., Xiang, Y.-B., Kweon, S.-S., Lee, K.-M., Blechter, B., Qian, B., Lu, D., Jeon, H.-S., Hsiao, C.-F., Sung, J.S., Tsai, Y.-H., Jung, Y.J., Chung, C.C., Burdett, L., Yeager, M., Hutchinson, A., Berndt, S.I., Pang, H., Choi, J.E., Park, K.H., Sung, S.W., Zhu, M., Guan, P., Tan, W., Hsin, M., Sit, K.-Y., Ho, J., Choi, Y.Y., Kim, J.S., Yoon, H.I., Park, I.K., Xu, P., He, Q., Perng, R.-P., Vermeulen, R., Lim, W.-Y., Chen, K.-C., Jin, L., Jiang, S.-S., Yamaji, T., Hicks, B., Wyatt, K., Dai, J., Jin, G., Song, B., Cheng, S., Cui, P., Iwasaki, M., Shimazu, T., Tsugane, S., Fei, K., Wu, G., Lin, H.-C., Fang, Y.-H., Tsai, F.-Y., Hsieh, W.-S., Yu, J., Stevens, V.L., Laird-Offringa, I.A., Marconett, C.N., Rieswijk, L., Chao, A., Shu, X.-O., Lin, D., Chen, K., Zhou, B., Kohno, T., Shen, H., Chanock, S.J., Rothman, N., Lan, Q., IRAS OH Epidemiology Chemical Agents, dIRAS RA-2, Wong, J.Y.Y., Hsiung, C.A., Matsuo, K., Wong, M.P., Seow, W.J., Song, M., Chang, I.-S., Chatterjee, N., Hu, W., Wu, C., Mitsudomi, T., Zheng, W., Kim, J.H., Seow, A., Caporaso, N.E., Shin, M.-H., Chung, L.P., An, S.-J., Zheng, H., Yatabe, Y., Kim, Y.T., Cai, Q., Kim, Y.-C., Bassig, B.A., Ho, J.C.M., Ji, B.-T., Daigo, Y., Ito, H., Momozawa, Y., Ashikawa, K., Kamatani, Y., Honda, T., Hosgood, H.D., Sakamoto, H., Kunitoh, H., Tsuta, K., Watanabe, S.-I., Kubo, M., Miyagi, Y., Nakayama, H., Matsumoto, S., Tsuboi, M., Goto, K., Song, L., Hua, X., Takahashi, A., Goto, A., Minamiya, Y., Shimizu, K., Tanaka, K., Wei, F., Matsuda, F., Kim, Y.H., Oh, I.-J., Song, F., Su, W.-C., Chang, G.-C., Chen, K.-Y., Chien, L.-H., Xiang, Y.-B., Kweon, S.-S., Lee, K.-M., Blechter, B., Qian, B., Lu, D., Jeon, H.-S., Hsiao, C.-F., Sung, J.S., Tsai, Y.-H., Jung, Y.J., Chung, C.C., Burdett, L., Yeager, M., Hutchinson, A., Berndt, S.I., Pang, H., Choi, J.E., Park, K.H., Sung, S.W., Zhu, M., Guan, P., Tan, W., Hsin, M., Sit, K.-Y., Ho, J., Choi, Y.Y., Kim, J.S., Yoon, H.I., Park, I.K., Xu, P., He, Q., Perng, R.-P., Vermeulen, R., Lim, W.-Y., Chen, K.-C., Jin, L., Jiang, S.-S., Yamaji, T., Hicks, B., Wyatt, K., Dai, J., Jin, G., Song, B., Cheng, S., Cui, P., Iwasaki, M., Shimazu, T., Tsugane, S., Fei, K., Wu, G., Lin, H.-C., Fang, Y.-H., Tsai, F.-Y., Hsieh, W.-S., Yu, J., Stevens, V.L., Laird-Offringa, I.A., Marconett, C.N., Rieswijk, L., Chao, A., Shu, X.-O., Lin, D., Chen, K., Zhou, B., Kohno, T., Shen, H., Chanock, S.J., Rothman, N., and Lan, Q.

Published
2020

22. OFP01.01 Liquid Biopsy to Detect MET Alterations in Patients with Advanced NSCLC: Biomarker Analysis from the VISION Study

Author

Le, X., primary, Kowalski, D., additional, Cho, B.C., additional, Conte, P., additional, Felip, E., additional, Garassino, M., additional, Viteri, S., additional, Chang, G.-C., additional, Richart, J., additional, Paz-Ares, L., additional, Juraeva, D., additional, Straub, J., additional, Stroh, C., additional, and Paik, P., additional

Published
2021
Full Text
View/download PDF

23. 1304P Brigatinib (BRG) vs crizotinib (CRZ) in Asian vs non-Asian patients (pts): Update from ALTA-1L

Author

Ahn, M-J., primary, Kim, H.R., additional, Yang, J.C-H., additional, Han, J-Y., additional, Li, J.Y-C., additional, Hochmair, M.J., additional, Chang, G-C., additional, Delmonte, A., additional, Lee, K.H., additional, Campelo, M.R. Garcia, additional, Gridelli, C., additional, Spira, A., additional, Califano, R., additional, Griesinger, F., additional, Ghosh, S., additional, Felip, E., additional, Kim, D-W., additional, Zhang, P., additional, Popat, S., additional, and Camidge, D.R., additional

Published
2020
Full Text
View/download PDF

25. CANOPY-A: A phase III, placebo-controlled study of canakinumab as adjuvant therapy in patients (pts) with surgically resected NSCLC

Author

Cho, B.C., primary, Chang, G.-C., additional, Kim, Y.-C., additional, Geater, S., additional, Saeteng, S., additional, Yang, C.-T., additional, Goto, Y., additional, Lu, S., additional, Ardizzoni, A., additional, Barlesi, F., additional, De Marchi, P., additional, Paz-Ares, L., additional, Spigel, D.R., additional, Thomas, M., additional, Garon, E.B., additional, Leung, M., additional, Baum, J., additional, Zewen, Z., additional, Mookerjee, B., additional, and Yang, J.C.-H., additional

Published
2019
Full Text
View/download PDF

27. ASTRIS real world study of osimertinib in patients (pts) with EGFR T790M NSCLC: Efficacy analysis by tissue or plasma T790M test

Author

Freitas, H.C., primary, Park, K., additional, Kim, D.-W., additional, Tiseo, M., additional, Hochmair, M.J., additional, Chang, G.-C., additional, Shi, Y.-K., additional, Moran, T., additional, Chen, Y., additional, Laskin, J., additional, Solomon, B., additional, Miranda, M., additional, Rigas, J., additional, Cheema, P.K., additional, and Kim, S.-W., additional

Published
2018
Full Text
View/download PDF

28. Effect of second-line ramucirumab in east Asian patients with refractory and aggressive disease: Subgroup analysis from REVEL and JVCG trials in non-small cell lung cancer

Author

Yoh, K., primary, Nakagawa, K., additional, Chang, G.-C., additional, Hosomi, Y., additional, Hsia, T.-C., additional, Tamura, T., additional, Cheng, R., additional, Varea, R., additional, Enatsu, S., additional, Hayden Zimmermann, A., additional, and Shih, J.-Y., additional

Published
2018
Full Text
View/download PDF

29. Choice of velocity variables for complex flow computation

Author

Shyy, W and Chang, G. C

Subjects
Fluid Mechanics And Heat Transfer
Abstract

The issue of adopting the velocity components as dependent velocity variables for the Navier-Stokes flow computations is investigated. The viewpoint advocated is that a numerical algorithm should preferably honor both the physical conservation law in differential form and the geometric conservation law in discrete form. With the use of Cartesian velocity vector, the momentum equations in curvilinear coordinates can retain the full conservation-law form and satisfy the physical conservation laws. With the curvilinear velocity components, source terms appear in differential equations and hence the full conservation law form can not be retained. In discrete expressions, algorithms based on the Cartesian components can satisfy the geometric conservation-law form for convection terms but not for viscous terms; those based on the curvilinear components, on the other hand, cannot satisfy the geometric conservation-law form for either convection or viscous terms. Several flow solutions for domain with 90 and 360 degree turnings are presented to illustrate the issues of using the Cartesian velocity components and the staggered grid arrangement.

Published
1991

30. Combination of the S49076 with gefitinib in NSCLC patients progressing on EGFR-TKI and harboring MET/AXL dysregulation

Author

Viteri, S., primary, Chang, G.-C., additional, Chiari, R., additional, Cho, B.C., additional, Ciardiello, F., additional, Curigliano, G., additional, Hida, T., additional, Lee, D.H., additional, Lim, W.T.D., additional, Lin, C.-C., additional, Martinez, A., additional, Murakami, H., additional, Natsume, I., additional, Nishio, M., additional, Paz-Ares, L., additional, Soo, R.A., additional, Cattan, V., additional, Gandossi, E., additional, Heck, H., additional, and Park, K., additional

Published
2018
Full Text
View/download PDF

31. EGFR mutation analysis for prospective patient (pt) selection in AURA3 Phase III trial of osimertinib vs platinum-pemetrexed (plt-pem) in pts with EGFR T790M positive advanced non-small cell lung cancer (NSCLC)

Author

Akamatsu, H., primary, Delmonte, A., additional, John, T., additional, Su, W-C, additional, Lee, J-S, additional, Chang, G-C, additional, Huang, X., additional, Jenkins, S., additional, Dearden, S., additional, and Wu, Y-L, additional

Published
2017
Full Text
View/download PDF

32. Ramucirumab in East Asian patients with stage IV non-small cell lung cancer after disease progression on platinum-based therapy: A pooled analysis of two randomized double-blind studies

Author

Shih, J-Y, primary, Yoh, K., additional, Hosomi, Y., additional, Chang, G-C, additional, Hsia, T-C, additional, Tamura, T., additional, Varea, R., additional, Nakamura, T., additional, Gallo, J., additional, Cheng, R., additional, Enatsu, S., additional, and Nakagawa, K., additional

Published
2017
Full Text
View/download PDF

35. Activity of afatinib in heavily pretreated patients (pts) with HER2 mutation-positive (HER2m+) advanced non-small cell lung cancer (NSCLC): findings from a global named patient use (NPU) program

Author

Peters, S., primary, Curioni-Fontecedro, A., additional, Nechushtan, H., additional, Shih, J.-Y., additional, Liao, W.-Y., additional, Gautschi, O., additional, Spataro, V., additional, Unk, M., additional, Yang, J.C.-H., additional, Lorence, R., additional, Carrière, P., additional, Cseh, A., additional, and Chang, G.-C., additional

Published
2017
Full Text
View/download PDF

43. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33

Author

Wang, Z., primary, Zhu, B., additional, Zhang, M., additional, Parikh, H., additional, Jia, J., additional, Chung, C. C., additional, Sampson, J. N., additional, Hoskins, J. W., additional, Hutchinson, A., additional, Burdette, L., additional, Ibrahim, A., additional, Hautman, C., additional, Raj, P. S., additional, Abnet, C. C., additional, Adjei, A. A., additional, Ahlbom, A., additional, Albanes, D., additional, Allen, N. E., additional, Ambrosone, C. B., additional, Aldrich, M., additional, Amiano, P., additional, Amos, C., additional, Andersson, U., additional, Andriole, G., additional, Andrulis, I. L., additional, Arici, C., additional, Arslan, A. A., additional, Austin, M. A., additional, Baris, D., additional, Barkauskas, D. A., additional, Bassig, B. A., additional, Beane Freeman, L. E., additional, Berg, C. D., additional, Berndt, S. I., additional, Bertazzi, P. A., additional, Biritwum, R. B., additional, Black, A., additional, Blot, W., additional, Boeing, H., additional, Boffetta, P., additional, Bolton, K., additional, Boutron-Ruault, M.-C., additional, Bracci, P. M., additional, Brennan, P., additional, Brinton, L. A., additional, Brotzman, M., additional, Bueno-de-Mesquita, H. B., additional, Buring, J. E., additional, Butler, M. A., additional, Cai, Q., additional, Cancel-Tassin, G., additional, Canzian, F., additional, Cao, G., additional, Caporaso, N. E., additional, Carrato, A., additional, Carreon, T., additional, Carta, A., additional, Chang, G.-C., additional, Chang, I.-S., additional, Chang-Claude, J., additional, Che, X., additional, Chen, C.-J., additional, Chen, C.-Y., additional, Chen, C.-H., additional, Chen, C., additional, Chen, K.-Y., additional, Chen, Y.-M., additional, Chokkalingam, A. P., additional, Chu, L. W., additional, Clavel-Chapelon, F., additional, Colditz, G. A., additional, Colt, J. S., additional, Conti, D., additional, Cook, M. B., additional, Cortessis, V. K., additional, Crawford, E. D., additional, Cussenot, O., additional, Davis, F. G., additional, De Vivo, I., additional, Deng, X., additional, Ding, T., additional, Dinney, C. P., additional, Di Stefano, A. L., additional, Diver, W. R., additional, Duell, E. J., additional, Elena, J. W., additional, Fan, J.-H., additional, Feigelson, H. S., additional, Feychting, M., additional, Figueroa, J. D., additional, Flanagan, A. M., additional, Fraumeni, J. F., additional, Freedman, N. D., additional, Fridley, B. L., additional, Fuchs, C. S., additional, Gago-Dominguez, M., additional, Gallinger, S., additional, Gao, Y.-T., additional, Gapstur, S. M., additional, Garcia-Closas, M., additional, Garcia-Closas, R., additional, Gastier-Foster, J. M., additional, Gaziano, J. M., additional, Gerhard, D. S., additional, Giffen, C. A., additional, Giles, G. G., additional, Gillanders, E. M., additional, Giovannucci, E. L., additional, Goggins, M., additional, Gokgoz, N., additional, Goldstein, A. M., additional, Gonzalez, C., additional, Gorlick, R., additional, Greene, M. H., additional, Gross, M., additional, Grossman, H. B., additional, Grubb, R., additional, Gu, J., additional, Guan, P., additional, Haiman, C. A., additional, Hallmans, G., additional, Hankinson, S. E., additional, Harris, C. C., additional, Hartge, P., additional, Hattinger, C., additional, Hayes, R. B., additional, He, Q., additional, Helman, L., additional, Henderson, B. E., additional, Henriksson, R., additional, Hoffman-Bolton, J., additional, Hohensee, C., additional, Holly, E. A., additional, Hong, Y.-C., additional, Hoover, R. N., additional, Hosgood, H. D., additional, Hsiao, C.-F., additional, Hsing, A. W., additional, Hsiung, C. A., additional, Hu, N., additional, Hu, W., additional, Hu, Z., additional, Huang, M.-S., additional, Hunter, D. J., additional, Inskip, P. D., additional, Ito, H., additional, Jacobs, E. J., additional, Jacobs, K. B., additional, Jenab, M., additional, Ji, B.-T., additional, Johansen, C., additional, Johansson, M., additional, Johnson, A., additional, Kaaks, R., additional, Kamat, A. M., additional, Kamineni, A., additional, Karagas, M., additional, Khanna, C., additional, Khaw, K.-T., additional, Kim, C., additional, Kim, I.-S., additional, Kim, J. H., additional, Kim, Y. H., additional, Kim, Y.-C., additional, Kim, Y. T., additional, Kang, C. H., additional, Jung, Y. J., additional, Kitahara, C. M., additional, Klein, A. P., additional, Klein, R., additional, Kogevinas, M., additional, Koh, W.-P., additional, Kohno, T., additional, Kolonel, L. N., additional, Kooperberg, C., additional, Kratz, C. P., additional, Krogh, V., additional, Kunitoh, H., additional, Kurtz, R. C., additional, Kurucu, N., additional, Lan, Q., additional, Lathrop, M., additional, Lau, C. C., additional, Lecanda, F., additional, Lee, K.-M., additional, Lee, M. P., additional, Le Marchand, L., additional, Lerner, S. P., additional, Li, D., additional, Liao, L. M., additional, Lim, W.-Y., additional, Lin, D., additional, Lin, J., additional, Lindstrom, S., additional, Linet, M. S., additional, Lissowska, J., additional, Liu, J., additional, Ljungberg, B., additional, Lloreta, J., additional, Lu, D., additional, Ma, J., additional, Malats, N., additional, Mannisto, S., additional, Marina, N., additional, Mastrangelo, G., additional, Matsuo, K., additional, McGlynn, K. A., additional, McKean-Cowdin, R., additional, McNeill, L. H., additional, McWilliams, R. R., additional, Melin, B. S., additional, Meltzer, P. S., additional, Mensah, J. E., additional, Miao, X., additional, Michaud, D. S., additional, Mondul, A. M., additional, Moore, L. E., additional, Muir, K., additional, Niwa, S., additional, Olson, S. H., additional, Orr, N., additional, Panico, S., additional, Park, J. Y., additional, Patel, A. V., additional, Patino-Garcia, A., additional, Pavanello, S., additional, Peeters, P. H. M., additional, Peplonska, B., additional, Peters, U., additional, Petersen, G. M., additional, Picci, P., additional, Pike, M. C., additional, Porru, S., additional, Prescott, J., additional, Pu, X., additional, Purdue, M. P., additional, Qiao, Y.-L., additional, Rajaraman, P., additional, Riboli, E., additional, Risch, H. A., additional, Rodabough, R. J., additional, Rothman, N., additional, Ruder, A. M., additional, Ryu, J.-S., additional, Sanson, M., additional, Schned, A., additional, Schumacher, F. R., additional, Schwartz, A. G., additional, Schwartz, K. L., additional, Schwenn, M., additional, Scotlandi, K., additional, Seow, A., additional, Serra, C., additional, Serra, M., additional, Sesso, H. D., additional, Severi, G., additional, Shen, H., additional, Shen, M., additional, Shete, S., additional, Shiraishi, K., additional, Shu, X.-O., additional, Siddiq, A., additional, Sierrasesumaga, L., additional, Sierri, S., additional, Loon Sihoe, A. D., additional, Silverman, D. T., additional, Simon, M., additional, Southey, M. C., additional, Spector, L., additional, Spitz, M., additional, Stampfer, M., additional, Stattin, P., additional, Stern, M. C., additional, Stevens, V. L., additional, Stolzenberg-Solomon, R. Z., additional, Stram, D. O., additional, Strom, S. S., additional, Su, W.-C., additional, Sund, M., additional, Sung, S. W., additional, Swerdlow, A., additional, Tan, W., additional, Tanaka, H., additional, Tang, W., additional, Tang, Z.-Z., additional, Tardon, A., additional, Tay, E., additional, Taylor, P. R., additional, Tettey, Y., additional, Thomas, D. M., additional, Tirabosco, R., additional, Tjonneland, A., additional, Tobias, G. S., additional, Toro, J. R., additional, Travis, R. C., additional, Trichopoulos, D., additional, Troisi, R., additional, Truelove, A., additional, Tsai, Y.-H., additional, Tucker, M. A., additional, Tumino, R., additional, Van Den Berg, D., additional, Van Den Eeden, S. K., additional, Vermeulen, R., additional, Vineis, P., additional, Visvanathan, K., additional, Vogel, U., additional, Wang, C., additional, Wang, J., additional, Wang, S. S., additional, Weiderpass, E., additional, Weinstein, S. J., additional, Wentzensen, N., additional, Wheeler, W., additional, White, E., additional, Wiencke, J. K., additional, Wolk, A., additional, Wolpin, B. M., additional, Wong, M. P., additional, Wrensch, M., additional, Wu, C., additional, Wu, T., additional, Wu, X., additional, Wu, Y.-L., additional, Wunder, J. S., additional, Xiang, Y.-B., additional, Xu, J., additional, Yang, H. P., additional, Yang, P.-C., additional, Yatabe, Y., additional, Ye, Y., additional, Yeboah, E. D., additional, Yin, Z., additional, Ying, C., additional, Yu, C.-J., additional, Yu, K., additional, Yuan, J.-M., additional, Zanetti, K. A., additional, Zeleniuch-Jacquotte, A., additional, Zheng, W., additional, Zhou, B., additional, Mirabello, L., additional, Savage, S. A., additional, Kraft, P., additional, Chanock, S. J., additional, Yeager, M., additional, Landi, M. T., additional, Shi, J., additional, Chatterjee, N., additional, and Amundadottir, L. T., additional

Published
2014
Full Text
View/download PDF

44. Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial)

Author

Ramalingam, S., primary, Crawford, J., additional, Chang, A., additional, Manegold, C., additional, Perez-Soler, R., additional, Douillard, J.-Y., additional, Thatcher, N., additional, Barlesi, F., additional, Owonikoko, T., additional, Wang, Y., additional, Pultar, P., additional, Zhu, J., additional, Malik, R., additional, Giaccone, G., additional, Della-Fiorentina, S., additional, Begbie, S., additional, Jennens, R., additional, Dass, J., additional, Pittman, K., additional, Ivanova, N., additional, Koynova, T., additional, Petrov, P., additional, Tomova, A., additional, Tzekova, V., additional, Couture, F., additional, Hirsh, V., additional, Burkes, R., additional, Sangha, R., additional, Ambrus, M., additional, Janaskova, T., additional, Musil, J., additional, Novotny, J., additional, Zatloukal, P., additional, Jakesova, J., additional, Klenha, K., additional, Roubec, J., additional, Vanasek, J., additional, Fayette, J., additional, Bennouna-Louridi, J., additional, Chouaid, C., additional, Mazières, J., additional, Vallerand, H., additional, Robinet, G., additional, Souquet, P.-J., additional, Spaeth, D., additional, Schott, R., additional, Lena, H., additional, Martinet, Y., additional, El Kouri, C., additional, Baize, N., additional, Scherpereel, A., additional, Molinier, O., additional, Fuchs, F., additional, Josten, K.M., additional, Marschner, N., additional, Schneller, F., additional, Overbeck, T., additional, Thomas, M., additional, von Pawel, J., additional, Reck, M., additional, Schuette, W., additional, Hagen, V., additional, Schneider, C.-P., additional, Georgoulias, V., additional, Varthalitis, I., additional, Zarogoulidis, K., additional, Syrigos, K., additional, Papandreou, C., additional, Bocskei, C., additional, Csanky, E., additional, Juhasz, E., additional, Losonczy, G., additional, Mark, Z., additional, Molnar, I., additional, Papai-Szekely, Z., additional, Tehenes, S., additional, Vinkler, I., additional, Almel, S., additional, Bakshi, A., additional, Bondarde, S., additional, Maru, A., additional, Pathak, A., additional, Pedapenki, R.M., additional, Prasad, K., additional, Prasad, S.V.S.S., additional, Kilara, N., additional, Gorijavolu, D., additional, Deshmukh, C.D., additional, John, S., additional, Sharma, L.M., additional, Amoroso, D., additional, Bajetta, E., additional, Bidoli, P., additional, Bonetti, A., additional, De Marinis, F., additional, Maio, M., additional, Passalacqua, R., additional, Cascinu, S., additional, Bearz, A., additional, Bitina, M., additional, Brize, A., additional, Purkalne, G., additional, Skrodele, M., additional, Baba, A.A., additional, Ratnavelu, K., additional, Saw, M.H., additional, Samson-Fernando, M.C., additional, Ladrera, G.E., additional, Jassem, J., additional, Koralewski, P., additional, Serwatowski, P., additional, Krzakowski, M., additional, Cebotaru, C., additional, Filip, D., additional, Ganea-Motan, D.E., additional, Ianuli, C.H., additional, Manolescu, I.G., additional, Udrea, A., additional, Burdaeva, O., additional, Byakhov, M., additional, Filippov, A., additional, Lazarev, S., additional, Mosin, I., additional, Orlov, S., additional, Udovitsa, D., additional, Khorinko, A., additional, Protsenko, S., additional, Lim, H.L., additional, Tan, Y.O., additional, Tan, E.H., additional, Bastus Piulats, R., additional, Garcia-Foncillas, J., additional, Valdivia, J., additional, de Castro, J., additional, Domine Gomez, M., additional, Kim, S.W., additional, Lee, J.-S., additional, Kim, H.K., additional, Lee, J.S., additional, Shin, S.W., additional, Kim, D.-W., additional, Kim, Y.-C., additional, Park, K.C., additional, Chang, C.-S., additional, Chang, G.-C., additional, Goan, Y.-G., additional, Su, W.-C., additional, Tsai, C.-M., additional, Kuo, H.-P., additional, Benekli, M., additional, Demir, G., additional, Gokmen, E., additional, Sevinc, A., additional, Haigentz, M., additional, Agarwal, M., additional, Pandit, S., additional, Araujo, R., additional, Vrindavanam, N., additional, Bonomi, P., additional, Berg, A., additional, Wade, J., additional, Bloom, R., additional, Amin, B., additional, Camidge, R., additional, Hill, D., additional, Rarick, M., additional, Flynn, P., additional, Klein, L., additional, Lo Russo, K., additional, Neubauer, M., additional, Richards, P., additional, Ruxer, R., additional, Savin, M., additional, Weckstein, D., additional, Rosenberg, R., additional, Whittaker, T., additional, Richards, D., additional, Berry, W., additional, Ottensmeier, C., additional, Dangoor, A., additional, Steele, N., additional, Summers, Y., additional, Rankin, E., additional, Rowley, K., additional, Giridharan, S., additional, Kristeleit, H., additional, Humber, C., additional, and Taylor, P., additional

Published
2013
Full Text
View/download PDF

45. Poster session 4. Molecular diagnosis & biomarkers

Author

Lynch, J. A., primary, Choi, C. M., additional, Park, Y. S., additional, Lee, J. C., additional, Park, M. J., additional, Kim, H. R., additional, Shih, N. Y., additional, Chang, G. C., additional, Tseng, S. W., additional, Liu, K. J., additional, Hsiao, K. C., additional, Lin, H. C., additional, Wang, J. Y., additional, Tsai, H. L., additional, Barak, V., additional, Chen, Y. J., additional, Hsieh, Y. L., additional, Chien, P. H., additional, Chien, Y. F., additional, Huang, W. C., additional, Lin, S. R., additional, Chung, F. Y., additional, Yen, L. C., additional, Rixe, O., additional, Salkeni, A. M., additional, Furgason, J. M., additional, McPherson, C., additional, Warnick, R., additional, Bahassi, M., additional, Hembrough, T. A., additional, Catenacci, D. V. T., additional, Liao, W. L., additional, Thyparambil, S., additional, Xu, P., additional, Henderson, L., additional, Burrows, J., additional, Bebb, D. G., additional, Elegbede, A. A., additional, Kubota, E., additional, Petersen, L. F., additional, Otsuka, S. M., additional, and Lees-Miller, S. P., additional

Published
2013
Full Text
View/download PDF

48. Thermal expansion mismatch and oxidation in thermal barrier coatings

Author

Chang, G. C, Phucharoen, W, and Miller, R. A

Subjects
Mechanical Engineering
Abstract

Thermal barrier coatings (TBC) for advanced gas turbine blades have been under intensive development during the last several years. This investigation is intended to achieve a clearer understanding of the mechanical behavior of plasma sprayed zirconia-yttria TBCs, involving a nickle-chromium-aluminum bond coat. The near term objectives are to study the stress states in a relatively simple model TBC subjected to steady state thermal loading. The resulting thermal expansion mismatch and oxidation have been primary targets for the study. The finite element approach and the effects of thermal mismatch and oxidation are described. A proposed mechanism for oxidation induced coating failure is also presented.

Published
1985

49. Finite element analysis of thermal barrier coatings

Author

Chang, G. C and Phucharoen, W

Subjects
Nonmetallic Materials
Abstract

The near-term objective is to develop an understanding of the states of stresses and strains in a Zirconia-yttria thermal barrier coating (TBC) experiencing a given temperature drop. Results so obtained are expected to facilitate experimental work. In order to gain realistic insights into the distribution of stresses and strains in a complex TBC, the finite element approach was selected to model a cylindrical TBC specimen. Experimental evidence reported in the literature indicated the presence of rough interface between the ceramic coat and bond coat. Oxidation of the bond coat at ceramic-bond interface was observed, as was a small amount of cracking in the ceramics near the ceramic-bond interface. To account for these complex features, a plane-strain finite element computer program known as TBCOC was developed, taking advantage of a generic computer code known as MARC. This generic code was made available through the use of a supercomputer (Cray 1). The TBCOC model contains 1316 nodal points and 2140 finite elements. It is capable of a uniform isothermal loading. Results of a sample computer run are presented.

Published
1985

50. Mechanical behavior of thermal barrier coatings for gas turbine blades

Author

Berndt, C. C, Phucharoen, W, and Chang, G. C

Subjects
Aircraft Propulsion And Power
Abstract

Plasma-sprayed thermal barrier coatings (TBCs) will enable turbine components to operate at higher temperatures and lower cooling gas flow rates; thereby improving their efficiency. Future developments are limited by precise knowledge of the material properties and failure mechanisms of the coating system. Details of this nature are needed for realistic modeling of the coating system which will, in turn, promote advancements in coating technology. Complementary experiments and analytical modeling which were undertaken in order to define and measure the important failure processes for plasma-sprayed coatings are presented. The experimental portion includes two different tests which were developed to measure coating properties. These are termed tensile adhesion and acoustic emission tests. The analytical modeling section details a finite element method which was used to calculate the stress distribution in the coating system. Some preliminary results are presented.

Published
1984

Catalog

Books, media, physical & digital resources
See catalog results